The aim of our study is to investigate the effects of rTMS applications at different current frequencies (low frequency / intermittent (intermittent) theta burst (iTBS)) in stroke patients on lower extremity motor development, physical function and quality of life, and to compare the effectiveness of these modalities.
Who can participate
Age range50 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Having lower extremity Brunnstrom motor stage in the 3-5 range,
* Having had a stroke at least six months ago,
* Being able to walk 5 meters independently with or without an assistive device,
* Ability to follow two-stage verbal commands,
* To agree to participate in the study voluntarily and regularly,
* Being medically stable (without a history of myocardial infarction, without musculoskeletal problems)
* Patients with a mini mental test of 24 and above will be accepted into our study.
Exclusion Criteria:
* Severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and a significant comorbid disease such as uncontrolled hypertension,
* Cognitive dysfunction,
* Visual impairment,
* Hearing problem,
* Malignancy and active infection,
* Skin infection in the rTMS application area,
* Open wound,
* Inflammatory disease,
* Epilepsy,
* Brain lesion or a history of drug use that will affect the seizure threshold,
* Patients with increased intracranial pressure or uncontrolled migraine will not be included.
What they're measuring
1
Change from baseline Functional Independence Measure (FIM) at 10th day and 6th week